Skip to Content
scroll

Appen (APX) $6.11

APX -28.70%: This has been a polarising stock in recent times with some analysts forecasting downgrades while others doubled down and increased their conviction on the buy side, today the stock fell ~30%  after missing FY21 earnings expectations and pulling FY22 guidance, in favour of longer term revenue targets which were big, a lot bigger than anyone in the market expected, however FY26 is a long way out into the never never. We were hopeful of a better outcome today but alas, the bearish camp led by Macquarie were right, and the stock fell hard. On the conference call it was clear that only analysts with a positive stance on the stock were engaging – Barrenjoey who had a buy equivalent and $15.40 PT remains optimistic as were Citi & Jeffries. While I got off the call thinking that Appen does have a good future, the next couple of years are going to be challenging, their visibility on the business is simply not there and that’s a function of their customers (big US tech mainly) going through rapid changes – hence why they have scrapped shorter term guidance. We had a 3% position in APX in the Flagship Growth Portfolio which we cut for a loss.

APX
MM is now neutral APX, cutting the position from our Growth Portfolio
Add To Hit List
chart
image description
Appen (APX)
image description

Relevant suggested news and content from the site

Back to top